These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 25748231)

  • 1. Extracorporeal photopheresis in prevention and treatment of acute GVHD.
    Kitko CL; Levine JE
    Transfus Apher Sci; 2015 Apr; 52(2):151-6. PubMed ID: 25748231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Favorable impact of extracorporeal photopheresis in acute and chronic graft versus host disease: Prospective single-center study.
    Sakellari I; Gavriilaki E; Batsis I; Mallouri D; Panteliadou AK; Lazaridou A; Vardi A; Constantinou V; Yannaki E; Papalexandri A; Kaloyannidis P; Smias C; Anagnostopoulos A
    J Clin Apher; 2018 Dec; 33(6):654-660. PubMed ID: 30394564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracorporeal photopheresis in acute and chronic graft-versus-host disease.
    Greinix HT; Worel N; Just U; Knobler R
    Transfus Apher Sci; 2014 Jun; 50(3):349-57. PubMed ID: 24780392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of extracorporeal photopheresis in chronic graft-versus-host disease.
    Radojcic V; Pletneva MA; Couriel DR
    Transfus Apher Sci; 2015 Apr; 52(2):157-61. PubMed ID: 25716169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of B Cells and Homing Marker on NK Cells Through Extracorporeal Photopheresis in Patients With Steroid-Refractory/Resistant Graft-Vs.-Host Disease Without Hampering Anti-viral/Anti-leukemic Effects.
    Wang L; Ni M; Hückelhoven-Krauss A; Sellner L; Hoffmann JM; Neuber B; Luft T; Hegenbart U; Schönland S; Kleist C; Sill M; Chen BA; Wuchter P; Eckstein V; Krüger W; Hilgendorf I; Yerushalmi R; Nagler A; Müller-Tidow C; Ho AD; Dreger P; Schmitt M; Schmitt A
    Front Immunol; 2018; 9():2207. PubMed ID: 30349527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent compounds for immunosuppression and experimental therapies for acute graft-versus-host disease.
    Michael M; Shimoni A; Nagler A
    Isr Med Assoc J; 2013 Jan; 15(1):44-50. PubMed ID: 23484241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracorporeal Photopheresis for Non-skin GvHD.
    Bittenbring J; Reichrath J
    Anticancer Res; 2016 Mar; 36(3):1395-6. PubMed ID: 26977041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracorporeal photopheresis in steroid-refractory acute or chronic graft-versus-host disease: results of a systematic review of prospective studies.
    Abu-Dalle I; Reljic T; Nishihori T; Antar A; Bazarbachi A; Djulbegovic B; Kumar A; Kharfan-Dabaja MA
    Biol Blood Marrow Transplant; 2014 Nov; 20(11):1677-86. PubMed ID: 24867779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the extracorporeal photopheresis in the management of the graft-versus-host disease.
    Kaloyannidis P; Mallouri D
    Transfus Apher Sci; 2012 Apr; 46(2):211-9. PubMed ID: 22123355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients.
    Weitz M; Strahm B; Meerpohl JJ; Bassler D
    Cochrane Database Syst Rev; 2014 Feb; (2):CD009898. PubMed ID: 24569961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracorporeal photopheresis in graft-versus-host disease.
    Carcagnì MR; De Aloe G; D'Ascenzo G; Rubegni P; Fimiani M
    J Dtsch Dermatol Ges; 2008 Jun; 6(6):451-7. PubMed ID: 18177413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracorporeal photopheresis versus alternative treatment for chronic graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients.
    Weitz M; Strahm B; Meerpohl JJ; Schmidt M; Bassler D
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD009898. PubMed ID: 26666581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarker profile predicts clinical efficacy of extracorporeal photopheresis in steroid-resistant acute and chronic graft-vs-host disease after allogenic hematopoietic stem cell transplant.
    Amat P; López-Corral L; Goterris R; Pérez A; López O; Heras I; Arbona C; Viguria MC; Hernández-Boluda JC; Martínez-Ruiz F; Martínez A; Solano C
    J Clin Apher; 2021 Oct; 36(5):697-710. PubMed ID: 34185332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UV treatment of chronic skin graft-versus-host disease--focus on UVA1 and extracorporeal photopheresis.
    Greinix HT; Tanew A
    Curr Probl Dermatol; 2012; 43():116-31. PubMed ID: 22377925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracorporeal Photopheresis for Treatment of Acute and Chronic Graft Versus Host Disease: An Italian Multicentric Retrospective Analysis on 94 Patients on Behalf of the Gruppo Italiano Trapianto di Midollo Osseo.
    Malagola M; Cancelli V; Skert C; Leali PF; Ferrari E; Tiburzi A; Sala ML; Donnini I; Chiusolo P; Mussetti A; Battista M; Turra A; Cattina F; Rambaldi B; Schieppati F; Polverelli N; Bernardi S; Perucca S; Marini M; Laszlo D; Savignano C; Patriarca F; Corradini P; Piccirillo N; Sica S; Bosi A; Russo D
    Transplantation; 2016 Dec; 100(12):e147-e155. PubMed ID: 27861297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracorporeal photopheresis in solid organ transplant-associated acute graft-versus-host disease.
    Houston BL; Yan M; Tinckam K; Kamel-Reid S; Chang H; Kuo KH; Tsien C; Seftel MD; Avitzur Y; Grant D; Cserti-Gazdewich CM
    Transfusion; 2016 Apr; 56(4):962-9. PubMed ID: 26892365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracorporeal photopheresis performed on the CELLEX® compared with the UVAR-XTS® instrument is more efficient and better tolerated in children with steroid-refractory graft-versus-host disease.
    Kapadia E; Wong E; Perez-Albuerne E; Jacobsohn D
    Pediatr Blood Cancer; 2015 Aug; 62(8):1485-8. PubMed ID: 25881179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracorporeal photopheresis in children with graft-versus-host disease.
    Chan KW
    J Clin Apher; 2006 Apr; 21(1):60-4. PubMed ID: 16619229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracorporeal photopheresis for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation.
    Shaughnessy PJ; Bolwell BJ; van Besien K; Mistrik M; Grigg A; Dodds A; Prince HM; Durrant S; Ilhan O; Parenti D; Gallo J; Foss F; Apperley J; Zhang MJ; Horowitz MM; Abhyankar S
    Bone Marrow Transplant; 2010 Jun; 45(6):1068-76. PubMed ID: 19915634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.